Mechanistically, T-DXd enhances tumor antigen presentation and CD8+ T cell infiltration through ADCC and the “bystander effect”, providing an ample effector cell basis for ICIs to lift immune suppression, thereby creating synergistic amplification. This evidence concerns the gene CD8A and neoplasm.